BioSpace News Archive

IMMUNOPRECISE ANTIBODIES LTD. today announced today announced that it will host a conference call to discuss its financial results and recent business highlights for third quarter fiscal year 2022, on Wednesday, March 16th, 2022, at 10:30 a.m. ET.

Revance Therapeutics, Inc. today announced it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA.

Yield10 Bioscience, Inc. today announced recent advances in the development of Camelina as a platform for the production of PHA bioplastic directly in the seed.

TC Biopharm (Holdings) PLC (“TC Biopharm” or the “Company”) (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, announces positive interim data its Phase 1a/2b human study evaluating safety and tolerability of TCB-002, OmnImmune®.

Blocked fallopian tubes are a major cause of female infertility, sending most women to surgery or in vitro fertilization (IVF).

BION has reimagined the world of dialysis technical operations, providing efficient, cost effective strategies to maintain dialysis equipment, nationwide.

DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the KeyBanc Life Sciences and Medtech Investor Forum being held virtually on Tuesday, March 22, 2022.

Strata Oncology, a precision oncology company advancing new molecular indications for cancer therapies, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2022.

ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500 liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc, which manufactures diagnostics enzymes and contracted custom products for use in medical diagnostics, pharmaceutical and industry.